Researchers Identify 60 Genetic Regions Linked to Liver Fat
An analysis of MRI scans and genomic data from over 71,000 individuals identified 31 previously unknown genetic locations tied to triglyceride accumulation.
What the Study Examined
Researchers at Karolinska Institutet analyzed genetic data alongside magnetic resonance imaging (MRI) scans from 71,488 people in the British United Kingdom (UK) Biobank database. The investigation evaluated the entire genome while simultaneously measuring liver fat levels using imaging technology.
The findings appeared in the journal Nature Genetics. This project represents the largest study to date that pairs genome-wide sequencing directly with MRI-based liver fat quantification.
Identification of New Genetic Variants
The analysis identified 60 independent genetic regions associated with liver triglyceride levels. Of those 60 regions, 31 had not been previously reported for this trait.
The study estimated that common genetic variants account for approximately 25% of the differences in liver fat between individuals. In addition, the researchers identified candidate genes likely involved in the condition for 48 of the 60 regions.
Genetic Risk Scores and Clinical Outcomes
The research team constructed a genetic risk score based on the identified variants to assess disease progression. Participants with the highest scores on the genetic scale developed fatty liver disease and liver cancer more frequently than those with the lowest scores.
The authors noted that hereditary traits governing early triglyceride accumulation in liver tissue correlate with more severe liver complications later in life.
Context for Metabolic Health Management
Fatty liver disease is defined by the buildup of triglycerides within the liver. While daily nutrition and metabolic factors influence liver lipid storage, this data shows that inherited variations explain about a quarter of the variation between individuals.
Individuals with a family history of liver disease or elevated liver markers on routine blood work can speak with their clinician about assessing their liver fat via noninvasive imaging.
Study Limitations and Next Steps
The study cohort was limited exclusively to individuals of European descent. The authors emphasized that larger trials across diverse population groups are required to determine whether these genetic associations apply globally.
Several of the 31 newly reported genetic regions also require replication in independent research cohorts to confirm their biological mechanisms.
Related Articles
Oral Semaglutide Adoption Outpaced Injectables at Launch
A study in Annals of Internal Medicine found early oral semaglutide adoption was 4.4 to 7.4...
Read article MetabolismPotassium Binder Eased Dietary Restriction Burden in Dialysis Trial
A clinical trial presented at ASN Kidney Week 2026 found sodium zirconium cyclosilicate lowered...
Read article MetabolismStudy Links 10 Healthy Dietary Patterns to Slower Biological Aging
Research in Nature Communications examining 7,500 people shows 10 healthy dietary patterns,...
Read article MetabolismStudy Links GLP-1 Drugs to Lower Macular Degeneration Risk
Adjusting for cardiometabolic health reveals glucagon-like peptide-1 receptor agonists are tied...
Read articleWant a clinician to work up your metabolic numbers?
Opt Health runs fasting insulin, A1C, a full lipid panel and 50+ other markers, then builds a treatment plan — GLP-1s included where they're appropriate — with a physician who reviews the data with you directly.
See Opt Health's metabolic program →Topic updates
Get the weekly metabolic health roundup
Insulin resistance, blood sugar, visceral fat, GLP-1 plateaus, metabolic syndrome, and weight-loss physiology.
Understand Your Health Better
Our free assessment maps your symptoms to the most relevant guides, tools, and product recommendations.
Take the Free Assessment →Free · Takes 5 minutes · Instant results